Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

7.540
-0.545-6.74%
Volume:1.94M
Turnover:14.82M
Market Cap:7.29B
PE:-62.83
High:8.055
Open:8.055
Low:7.480
Close:8.085
52wk High:15.750
52wk Low:6.230
Shares:967.00M
HK Float Shares:967.00M
Volume Ratio:2.38
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.120
ROE:-9.98%
ROA:-5.47%
PB:3.72
PE(LYR):-62.83
PS:12.02

Loading ...

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Alphamab Oncology Maintains Steady Share Base in April 2026, Confirms Adequate Public Float

Bulletin Express
·
May 07

Alphamab Oncology Swings to Loss in 2025

MT Newswires Live
·
Apr 29

ALPHAMAB-B 2025年营收5.66亿元 研发投入攀升至5.72亿元致净亏1.14亿元

Bulletin Express
·
Apr 28

Alphamab Oncology publishes 2025 annual report

Reuters
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

ALPHAMAB-B Grants 250,000 Award Shares to Two Employees

Stock News
·
Apr 23

Alphamab Oncology grants 250,000 restricted share awards to employees under incentive scheme

Reuters
·
Apr 23

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

ALPHAMAB-B Secures Three-Year HKEX Waiver to Appoint Jiang Rui as Joint Company Secretary

Bulletin Express
·
Apr 22

ALPHAMAB-B's KN026 Breast Cancer Trial Results Selected for Oral Presentation at 2026 ASCO Annual Meeting

Stock News
·
Apr 22

Alphamab Oncology: KN026 Phase III Neoadjuvant Breast-Cancer Results Chosen for 2026 ASCO Late-Breaking Oral Session

Bulletin Express
·
Apr 22

Alphamab Oncology says KN026 Phase III neoadjuvant breast cancer results selected for ASCO LBA oral session

Reuters
·
Apr 22

ALPHAMAB-B Shares Surge Over 12% in Morning Session as KN026 Commercialization Nears

Stock News
·
Apr 13

ALPHAMAB-B Announces Appointment of Jiang Rui as Joint Company Secretary

Stock News
·
Apr 08

Alphamab Oncology names Jiang Rui joint company secretary, authorized representative

Reuters
·
Apr 08